author_facet Nazarenko, Irina
Schäfer, Reinhold
Sers, Christine
Nazarenko, Irina
Schäfer, Reinhold
Sers, Christine
author Nazarenko, Irina
Schäfer, Reinhold
Sers, Christine
spellingShingle Nazarenko, Irina
Schäfer, Reinhold
Sers, Christine
Journal of Cell Science
Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
Cell Biology
author_sort nazarenko, irina
spelling Nazarenko, Irina Schäfer, Reinhold Sers, Christine 1477-9137 0021-9533 The Company of Biologists Cell Biology http://dx.doi.org/10.1242/jcs.000018 <jats:p>HRSL3 (also known as H-REV107-1) belongs to a class II tumor suppressor gene family and is downregulated in several human tumors including ovarian carcinomas. To unravel the mechanism of HRSL3 tumor suppressor action, we performed a yeast two-hybrid screen and identified the α-isoform of the regulatory subunit A of protein phosphatase 2A (PR65α) as a new interaction partner of HRSL3. Interaction between HRSL3 and PR65α was confirmed in vitro and by co-immunoprecipitation in mammalian cells. We demonstrate that HRSL3 binds to the endogenous PR65α, thereby partially sequestering the catalytic subunit PR36 from the PR65 protein complex, and inhibiting PP2A catalytic activity. Furthermore, binding of HRSL3 to PR65 induces apoptosis in ovarian carcinoma cells in a caspase-dependent manner. Using several mutant HRSL3 constructs, we identified the N-terminal proline-rich region within the HRSL3 protein as the domain that is relevant for both binding of PR65α and induction of programmed cell death. This suggests that the negative impact of HRSL3 onto PP2A activity is important for the HRSL3 pro-apoptotic function and indicates a role of PP2A in survival of human ovarian carcinomas. The analysis of distinct PP2A target molecules revealed PKCζ as being involved in HRSL3 action. These data implicate HRSL3 as a signaling regulatory molecule, which is functionally involved in the oncogenic network mediating growth and survival of ovarian cancer cells.</jats:p> Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells Journal of Cell Science
doi_str_mv 10.1242/jcs.000018
facet_avail Online
Free
finc_class_facet Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTI0Mi9qY3MuMDAwMDE4
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTI0Mi9qY3MuMDAwMDE4
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint The Company of Biologists, 2007
imprint_str_mv The Company of Biologists, 2007
issn 1477-9137
0021-9533
issn_str_mv 1477-9137
0021-9533
language English
mega_collection The Company of Biologists (CrossRef)
match_str nazarenko2007mechanismsofthehrsl3tumorsuppressorfunctioninovariancarcinomacells
publishDateSort 2007
publisher The Company of Biologists
recordtype ai
record_format ai
series Journal of Cell Science
source_id 49
title Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
title_unstemmed Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
title_full Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
title_fullStr Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
title_full_unstemmed Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
title_short Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
title_sort mechanisms of the hrsl3 tumor suppressor function in ovarian carcinoma cells
topic Cell Biology
url http://dx.doi.org/10.1242/jcs.000018
publishDate 2007
physical 1393-1404
description <jats:p>HRSL3 (also known as H-REV107-1) belongs to a class II tumor suppressor gene family and is downregulated in several human tumors including ovarian carcinomas. To unravel the mechanism of HRSL3 tumor suppressor action, we performed a yeast two-hybrid screen and identified the α-isoform of the regulatory subunit A of protein phosphatase 2A (PR65α) as a new interaction partner of HRSL3. Interaction between HRSL3 and PR65α was confirmed in vitro and by co-immunoprecipitation in mammalian cells. We demonstrate that HRSL3 binds to the endogenous PR65α, thereby partially sequestering the catalytic subunit PR36 from the PR65 protein complex, and inhibiting PP2A catalytic activity. Furthermore, binding of HRSL3 to PR65 induces apoptosis in ovarian carcinoma cells in a caspase-dependent manner. Using several mutant HRSL3 constructs, we identified the N-terminal proline-rich region within the HRSL3 protein as the domain that is relevant for both binding of PR65α and induction of programmed cell death. This suggests that the negative impact of HRSL3 onto PP2A activity is important for the HRSL3 pro-apoptotic function and indicates a role of PP2A in survival of human ovarian carcinomas. The analysis of distinct PP2A target molecules revealed PKCζ as being involved in HRSL3 action. These data implicate HRSL3 as a signaling regulatory molecule, which is functionally involved in the oncogenic network mediating growth and survival of ovarian cancer cells.</jats:p>
container_issue 8
container_start_page 1393
container_title Journal of Cell Science
container_volume 120
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792337368381915136
geogr_code not assigned
last_indexed 2024-03-01T15:15:14.318Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Mechanisms+of+the+HRSL3+tumor+suppressor+function+in+ovarian+carcinoma+cells&rft.date=2007-04-15&genre=article&issn=0021-9533&volume=120&issue=8&spage=1393&epage=1404&pages=1393-1404&jtitle=Journal+of+Cell+Science&atitle=Mechanisms+of+the+HRSL3+tumor+suppressor+function+in+ovarian+carcinoma+cells&aulast=Sers&aufirst=Christine&rft_id=info%3Adoi%2F10.1242%2Fjcs.000018&rft.language%5B0%5D=eng
SOLR
_version_ 1792337368381915136
author Nazarenko, Irina, Schäfer, Reinhold, Sers, Christine
author_facet Nazarenko, Irina, Schäfer, Reinhold, Sers, Christine, Nazarenko, Irina, Schäfer, Reinhold, Sers, Christine
author_sort nazarenko, irina
container_issue 8
container_start_page 1393
container_title Journal of Cell Science
container_volume 120
description <jats:p>HRSL3 (also known as H-REV107-1) belongs to a class II tumor suppressor gene family and is downregulated in several human tumors including ovarian carcinomas. To unravel the mechanism of HRSL3 tumor suppressor action, we performed a yeast two-hybrid screen and identified the α-isoform of the regulatory subunit A of protein phosphatase 2A (PR65α) as a new interaction partner of HRSL3. Interaction between HRSL3 and PR65α was confirmed in vitro and by co-immunoprecipitation in mammalian cells. We demonstrate that HRSL3 binds to the endogenous PR65α, thereby partially sequestering the catalytic subunit PR36 from the PR65 protein complex, and inhibiting PP2A catalytic activity. Furthermore, binding of HRSL3 to PR65 induces apoptosis in ovarian carcinoma cells in a caspase-dependent manner. Using several mutant HRSL3 constructs, we identified the N-terminal proline-rich region within the HRSL3 protein as the domain that is relevant for both binding of PR65α and induction of programmed cell death. This suggests that the negative impact of HRSL3 onto PP2A activity is important for the HRSL3 pro-apoptotic function and indicates a role of PP2A in survival of human ovarian carcinomas. The analysis of distinct PP2A target molecules revealed PKCζ as being involved in HRSL3 action. These data implicate HRSL3 as a signaling regulatory molecule, which is functionally involved in the oncogenic network mediating growth and survival of ovarian cancer cells.</jats:p>
doi_str_mv 10.1242/jcs.000018
facet_avail Online, Free
finc_class_facet Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTI0Mi9qY3MuMDAwMDE4
imprint The Company of Biologists, 2007
imprint_str_mv The Company of Biologists, 2007
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 1477-9137, 0021-9533
issn_str_mv 1477-9137, 0021-9533
language English
last_indexed 2024-03-01T15:15:14.318Z
match_str nazarenko2007mechanismsofthehrsl3tumorsuppressorfunctioninovariancarcinomacells
mega_collection The Company of Biologists (CrossRef)
physical 1393-1404
publishDate 2007
publishDateSort 2007
publisher The Company of Biologists
record_format ai
recordtype ai
series Journal of Cell Science
source_id 49
spelling Nazarenko, Irina Schäfer, Reinhold Sers, Christine 1477-9137 0021-9533 The Company of Biologists Cell Biology http://dx.doi.org/10.1242/jcs.000018 <jats:p>HRSL3 (also known as H-REV107-1) belongs to a class II tumor suppressor gene family and is downregulated in several human tumors including ovarian carcinomas. To unravel the mechanism of HRSL3 tumor suppressor action, we performed a yeast two-hybrid screen and identified the α-isoform of the regulatory subunit A of protein phosphatase 2A (PR65α) as a new interaction partner of HRSL3. Interaction between HRSL3 and PR65α was confirmed in vitro and by co-immunoprecipitation in mammalian cells. We demonstrate that HRSL3 binds to the endogenous PR65α, thereby partially sequestering the catalytic subunit PR36 from the PR65 protein complex, and inhibiting PP2A catalytic activity. Furthermore, binding of HRSL3 to PR65 induces apoptosis in ovarian carcinoma cells in a caspase-dependent manner. Using several mutant HRSL3 constructs, we identified the N-terminal proline-rich region within the HRSL3 protein as the domain that is relevant for both binding of PR65α and induction of programmed cell death. This suggests that the negative impact of HRSL3 onto PP2A activity is important for the HRSL3 pro-apoptotic function and indicates a role of PP2A in survival of human ovarian carcinomas. The analysis of distinct PP2A target molecules revealed PKCζ as being involved in HRSL3 action. These data implicate HRSL3 as a signaling regulatory molecule, which is functionally involved in the oncogenic network mediating growth and survival of ovarian cancer cells.</jats:p> Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells Journal of Cell Science
spellingShingle Nazarenko, Irina, Schäfer, Reinhold, Sers, Christine, Journal of Cell Science, Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells, Cell Biology
title Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
title_full Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
title_fullStr Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
title_full_unstemmed Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
title_short Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
title_sort mechanisms of the hrsl3 tumor suppressor function in ovarian carcinoma cells
title_unstemmed Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
topic Cell Biology
url http://dx.doi.org/10.1242/jcs.000018